• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Adding Fabrication Capabilities: Additive Manufacturing for Production Parts

    Delivering the Goods: The Evolving World of Combination Products

    Anxious Undertones: The 2019 Year in Review

    From Art to Science: The Changing Face of Extrusion

    Exact Science: A Micromolding Roundtable
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Top News
    FDA OKs World's First Single-Use Duodenoscope

    Dr. Stephen Hahn Confirmed as New FDA Leader

    FDA OKs First Test to Help Screen for Newborn Duchenne Muscular Dystrophy

    MedStar Health and Cleveland Clinic Innovations Awarded Grant

    3M to Sell Drug Delivery Business for $650M
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Adding Fabrication Capabilities: Additive Manufacturing for Production Parts

    Delivering the Goods: The Evolving World of Combination Products

    Anxious Undertones: The 2019 Year in Review

    From Art to Science: The Changing Face of Extrusion

    Exact Science: A Micromolding Roundtable
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    From Genome Sequencing to the World’s First Portable MRI

    An Update on Digital Health

    ‘If You’re Reading This, You Need to Be at This Meeting’

    Five Steps for Succeeding Globally in Medtech

    Unlocking Market Doors with Real-World Evidence
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Fusion Biotec Inc.

    Pulse Systems

    Carclo Technical Plastics

    Marox Corporation

    Eurofins Medical Device Testing
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    EU's MDR: Irresistible Force Meets Immovable Object

    Ladies First: An Examination of the Women's Health Device Industry

    Localizing Medical Devices

    Sounding Board: Looking Back at 2019 and Gazing at 2020

    Understanding Key Processes for Mixing APIs with Silicone
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Glenbrook Technologies Inc.

    Eurofins Medical Device Testing

    Halkey-Roberts Corporation

    Accumold

    Pulse Systems
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • Podcasts
    • Resources
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Breaking News

    6 Fraunhofer Research Demonstrations to See at Medica

    Check out the latest research from Europe's largest application-oriented research organization.

    6 Fraunhofer Research Demonstrations to See at Medica
    Related CONTENT
    • Origami Inspires New Biomaterial for Tissue Regeneration
    • Home Field Advantage: Examining Home Diagnostics for Chronic Disease
    • 3D Human Heart Ventricle Model Beats and Survives Months in the Lab
    • 20. Smith & Nephew plc
    • 15. Zimmer Biomet
    Fraunhofer-Gesellschaft11.12.18
    Visit the Fraunhofer booths at the world's leading trade fair for the medical industry from 12th to 15th November 2018 in Düsseldorf to get a firsthand look at the following innovations poised to transform medical care:

    1. Electrowetting (Hall 8a, Booth P13) and Telemedicine (Hall 10, Booth G05)
    Researchers at Fraunhofer FIT have developed a system that now allows monitoring biochemical reactions at the single-molecule level from start to finish. It is based on the physical effect of Electrowetting-On-Dielectric (EWOD), widely used in microfluidics. The EWOD-BioPro system is capable of merging reagent droplets as small as 150nl with very high precision. This allows monitoring of the reaction process using a confocal microscope adapted at FIT, and to record high-resolution measurements.
     
    "For the first time, we can observe the details of how the two droplets interact at the single-molecule level—thus allowing us to monitor the entire chain of events," said Lorenz Sparrenberg from the Fraunhofer Institute for Applied Information Technology FIT, who is leading the research project.
     
    Biological interactions under conditions closely resembling those that occur naturally in the human body can this be studied. In pharmacology, for example, it is important to understand the effects of drug ingredients as precisely as possible and know when these effects occur. But the combination of EWOD and confocal microscopy may also be used to study the interaction between complementary DNA strands, antibodies and antigens, or enzyme-substrate reactions.
     
    Conventional laboratory tests not only deliver less information but also require much higher quantities of the sample liquids, and take longer to perform. The typical duration of an enzymatic assay, for example, is around 15—20 minutes. The EWOD-BioPro system can present the results within 30 seconds. It may thus be a further step toward point-of-care diagnostics.


    The EWOD-BioPro wetting-on-dielectric makes it easier to understand biological interactions. Image courtesy of Fraunhofer FIT.
     
    The teliFIT platform features a modular, expandable architecture. It can accommodate a multitude of user groups with their specific access rights and can easily be tailored to a wide range of design requirements, contents, and functions. The platform's current functionalities may be grouped into five categories: Communication, Monitoring, Analysis, Smart Data Services, and Safety & Security. Individual functions can be activated or extended as required.
     
    Smart devices can be used to capture and upload data to the teliFIT platform. Processing results are presented in visually attractive charts, but also offer relevant context. For example, teliFIT offers a nutrition diary that automatically evaluates the calories taken in against the user's individual basic requirement. Actual intake is also evaluated in relation to agreed nutritional goals.
     
    Data security has been a major design criterion for the teliFIT platform. Personal data is routinely encrypted and stored in a separate database. The teliFIT platform is hosted in Germany. Its resilience is checked regularly through external penetration tests. There is a stable code base that includes high-quality software and architecture. Due to the use of state-of-the-art software technologies, the platform is easily scalable.
     
    2. Artificial Intelligence for Optimal Patient Care (Hall 10, Stand G05)
    Special software developed by the Fraunhofer Institute for Computer Graphics Research will soon assist health professionals in analysis of imaging data and also automatically generate a “virtual biopsy,” localizing and highlighting the tumor, displaying it three-dimensionally and analyzing the data. This will allow the software to derive over a hundred parameters from the CT images of a head and neck tumor. Initial results show that this approach not only analyzes CT images more quickly, it also provides information that could only be obtained through a surgical procedure and subsequent lab testing of the biopsied tissue. Aside from imaging organs and body regions, artificial intelligence is making it possible to automatically segment and analyze imaging data that is difficult to interpret.
     
    Another interesting question doctors face is whether there are noticeable connections between the person being treated and other people. To answer this, health professionals combine the data of people with similar clinical pictures or other similarities, such as age or gender, into cohorts. The researchers at Fraunhofer IGD have developed software to assist doctors in forming suitable cohorts, examines them for significant connections, visualizes the attributes, and facilitates and accelerates the identification of clinically relevant hypotheses. What took several hours to do manually will take this automatic process mere seconds—valuable time gained for treating the patient. Incorporating artificial intelligence in the search for a hypothesis also ensures that a potentially critical factor is not overlooked.


    Fraunhofer IGD’s visual solution combines all digitally available data into a graphic overview. Image courtesy of Fraunhofer IGD - everythingpossible/Fotolia.
     
    Created by compiling all relevant parameters, the patient’s “digital twin” contributes to optimal care. Health@Hand, Fraunhofer IGD’s visual solution, combines all digitally available data, including the patient’s real-time vitals, into a graphic overview. As a digital control station, the system provides hospital staff with all relevant information with just a click and reprocesses it visually. This means necessary information is collected considerably more quickly. However, the control station is not content with just showing a single patient, rather it shows a live 3D model of the entire hospital ward, including inventory. Doctors and nurses can view the digital twin of the station on a PC or tablet and immediately know where, for example, a mobile X-ray machine is currently located. Key data for the entire ward can either be displayed all at once or viewed in detail for a single room or over a given period, for example. The goal is to simplify ward monitoring, detect disturbances immediately and thus be able to intervene in time.
     
    To analyze an individual’s health information, the Health@Hand system links together crucial data from different clinical data systems to make possible entirely new conclusions. Trends in the patient’s health can be identified sooner and prognoses for the treatment process made more quickly. To maintain a patient’s health even at home, continuously recorded vitals can be supplied directly to the system. This would be sensible for, say, diabetes: The doctor immediately sees when levels exceed normal range and can take appropriate action. Even vitals and activity data from wearables, such as fitness armbands or smartwatches, can be included in the system, allowing it to act as a personal health assistant and make a valuable contribution to prevention.
     

    Antibiotic coating lyses bacterium (E. coli). Image courtesy of Fraunhofer IFAM.
    3. No Chance for Bacteria on Implants (Hall 8a, Booth P13)
    As part of the “Synergy-Boost” project, researchers at the Fraunhofer Institutes for Manufacturing Technology and Advanced Materials IFAM, for Molecular Biology and Applied Ecology IME, for Cell Therapy and Immunology IZI, and for Toxicology and Experimental Medicine ITEM have together developed a technique for preventing further hip joint infection. “We apply the antibiotic needed directly to the second implant—bringing it right to the spot where it’s needed,” said Kai Borcherding, a scientist at Fraunhofer IFAM. “We also did research on how antibiotics and silver ions work synergistically, significantly increasing the efficacy of the drug.” While both the antibiotic and the silver ions can eliminate pathogens, their combined effect is much stronger than the sum of their individual effects—they reinforce each other.
     
    Silver ions have long been known to substantially enhance the effect of antibiotics, but research into the mechanism has been limited to isolated experiments. The optimal ratio of silver ions to antibiotic molecules is dependent not only on the drug used, but also on which microorganism is to be killed. The researchers at Fraunhofer IME initially performed large-scale screenings. They investigated 20 different antibiotics with various ratios of silver ions and on four key pathogens—a total of more than 9000 tests—to identify the most effective combinations.
     
    If patients suffer from an infection and need a new hip joint or a new dental implant, the first thing the physician will do is to generate an antibiogram. Suitable sample material is taken, the microorganisms from it are cultivated and then analyzed to identify the appropriate antibiotic. This is a standard procedure. The physician then applies the appropriate antibiotic directly to the implant. “At Fraunhofer IFAM, we have already investigated how the antibiotics can be stored, and developed various coating methods to do this,” said Borcherding. The researchers have found a way to structure the surface so that it absorbs the antibiotic. In a vacuum, they apply the coating containing silver to the surface of the implant. Development of the coating process is now complete. Researchers at Fraunhofer IZI and Fraunhofer ITEM must now verify its efficacy. Researchers at Fraunhofer ITEM are also preparing the documentation required for approval of medical devices.
     
    4. Individualized Therapy for Patients with Osteoporosis (Hall 10, Booth G05/H04)
    Drug therapies are intended to inhibit bone depletion, but patients often do not respond to treatment. Studies also indicate a link between osteoporosis and cardiovascular diseases. Furthermore, the primary therapy for loss of bone mass is to increase calcium intake, the mineral is said to increase the stability of the bones. But raising the dosage of the mineral can lead to calcium deposits in veins, leading potentially to an increased risk of vascular occlusion and heart attack. The OsteoSys project therefore aims to investigate the interactions between cardiovascular diseases, inflammation, and bone metabolism, with a view to providing patients with personalized therapy and minimizing drug-related side effects.
     
    Whether genetic or epigenetic (the influence of the environment on genes), the scientists take factors at the level of cells or organs into account to develop biomarkers and algorithms that predict adverse effects and enable patients to receive individualized treatment.
     
    The role of the Fraunhofer FIT researchers in Sankt Augustin is to integrate data and create algorithms and models for the project. They are also establishing a sample management system and biobank management tools. “The software we develop to manage samples and laboratory procedures supports physicians in handling samples. Efficient data management supports our partners in their research work through the secure and traceable exchange of data, samples, and information,” said Carina Goretzky, a scientist at Fraunhofer FIT.
     
    5. Interactive Shutter Eyeglasses to Replace Eyepatch Therapy (Hall 10, Booth G05/H04)
    In a collaborative project, research and industry are aiming to achieve a decisive improvement in the often difficult therapy for young children with amblyopia (lazy eye). They hope that new interactive, context-dependent shutter eyeglasses with sensor-based feedback will increase treatment compliance for this complaint. This new technology covers up the patient’s good eye only when the situation is appropriate. During sport, for example, or other activities that demand good spatial vision, this function is deactivated so as to avoid any risk of accident.
     
    Use and operation of the shutter eyeglasses are controlled by a multimodal sensor system integrated in the temples of the eyeglasses. Researchers at Fraunhofer Institute for Biomedical Engineering IBMT have developed this new technology along with a smartphone app to enable parents to monitor the treatment. All the data generated by this technology is compiled in a digital patient file system, which was also developed by the IBMT team. This web-based application is compliant with data-protection laws and can be accessed by the ophthalmologist in order to monitor, adjust and enhance treatment. For example, it tells the doctor if and when the patient has worn the eyeglasses—information that was never available with conventional treatment. “The data is uploaded to the app via Bluetooth and then securely archived in a cloud database,” explained Dr. Frank Ihmig, a scientist at Fraunhofer IBMT in St. Ingbert. “Our goal is to provide an individual, patient-based therapy.”


    Functional model of electronic shutter eyeglasses. Image courtesy of Fraunhofer IBMT, Bernd Müller.
     
    Data for real-time processing is generated by various sensors. These include temperature and skin-contact sensors to monitor the length of time and the position in which the eyeglasses have been worn. They also measure the occlusion phases, during which the LCD lenses are darkened. “This data is logged in an electronic memory device integrated in the eyeglass frames,” Ihmig explained. The eyeglass lenses are darkened by means of an electronically controlled shuttering system based on integrated liquid crystals. The frequency and duration of the occlusion therapy can be individually adjusted to each specific case. It is therefore more versatile than conventional eyepatch treatment. In this way, project partners hope to encourage young patients to wear the eyeglasses for the prescribed duration. The skin-contact sensors monitor whether the eyeglasses are being worn in the correct position and even provide the young wearer with child-friendly feedback. This can help increase acceptance for this form of therapy, too.
     
    An acceleration sensor recognizes specific patterns of movement and can distinguish between different activities such as standing up, lying down, sitting down, walking, running, jumping, cycling and climbing stairs. “Our shutter eyeglasses are context-sensitive,” Ihmig explained. “This means that when the wearer is involved in energetic activities such as sport, for example, the mechanism for darkening the LCD lenses is deactivated, and they remain clear. This ensures full spatial vision and removes the risk of the wearer being involved in an accident.”
     
    Initial tests with amblyopic children are scheduled for the second quarter of 2019. In addition, it is hoped that a validation study to be conducted toward the end of the project will confirm the medical benefits of the therapy.
     
    Researchers have already developed a first functional model of the electronics for the new eyeglasses. The next step will be to make these smaller so they can be integrated in children’s eyeglass frames. In parallel, they are working to make the electronics more energy-efficient and thereby prolong battery life. The battery is recharged inductively, i.e., without a cable.
     
    6. The Fast Way to Individual Treatment: Automated Tumor Diagnosis (Hall 10 Booth G05)
    Fraunhofer researchers have developed an automated procedure for lymph node diagnosis as part of an inter-disciplinary project. The method provides important information on the stage of cancer: Cells from a primary tumor can make their way to other parts of the body through the lymph system and form metastases. Therefore, the presence of tumor cells in the lymph nodes means that the cancer has already spread and must be treated accordingly.
     
    Until now, the lymph node tissue taken from patients has been solidified in paraffin in the laboratory, sliced into thin segments and examined under a microscope. “However, as pathologists are not able to examine all segments due to time constraints, some tumor cells may remain undiscovered,” explained Sebastian Schoening, group leader of the project group for Automation in Medicine and Biotechnology at Fraunhofer IPA.
     
    The new method that the researchers from three Fraunhofer institutes have developed means that all tumor cells can be detected.



    Lymph node diagnosis helps to determine whether a tumor has already spread across the body and started to form metastases. Image courtesy of Fraunhofer IPA.
     
    “This is a radically different approach to previous lymph node diagnosis,” explained Schöning. Instead of cutting tissue, the samples are dissociated into individual cells. The grinding device required for this procedure, the so-called “Tissue Grinder,” was developed by the IPA team. The trick is that cells are being so carefully separated that they still function. In the next phase, tumor cells are colored, analyzed under the microscope, and counted. All of this is fully automated without a laboratory technician. The expertise for this system was contributed by the research team at the Fraunhofer Institute for Integrated Circuits IIS. The tumor cells are subsequently examined for genetic changes in order to select the optimal treatment for individual patients. This molecular test method was developed at the Fraunhofer Institute for Toxicology and Experimental Medicine ITEM in Regensburg. The software Merlin, developed by the IPA team, digitizes the entire procedure and makes it available in an electronic lab notebook covering all laboratory steps: from processing the samples to filing the findings report.
     
    Automation not only makes the new LyDia HD diagnosis more precise but also quicker and more cost-effective than previous methods. Additionally, it immediately provides important information on the nature of the tumor cells for further treatment. This helps doctors to select suitable medication for the patient as part of a follow-up treatment plan.
    Related Searches
    • tissue
    • x-ray
    • eye
    • Medical Devices
    Related Knowledge Center
    • Diagnostics
    • Electronics
    • Software & IT
    Suggested For You
    Control with Your Feet: A Computer Game to Help Prevent Thrombosis Control with Your Feet: A Computer Game to Help Prevent Thrombosis
     Sensera Achieves ISO 13485 Quality Certification Sensera Achieves ISO 13485 Quality Certification
    The Top 10 Medical Innovations for 2019 The Top 10 Medical Innovations for 2019
    Philips Launches First Startup Collaboration Program for AI in Healthcare Philips Launches First Startup Collaboration Program for AI in Healthcare
    Drug-Equipped Polymer Fibers: Medication You Can Wear Drug-Equipped Polymer Fibers: Medication You Can Wear
    AI System Finds Subtle Clues in Medical Images AI System Finds Subtle Clues in Medical Images
    Tissue Analytics Launches 3D Wound Imaging for Smartphones Tissue Analytics Launches 3D Wound Imaging for Smartphones
    Whole-Brain Connectome Maps Teach AI to Predict Epilepsy Outcomes Whole-Brain Connectome Maps Teach AI to Predict Epilepsy Outcomes
    Driving Toward Custom Electronics Driving Toward Custom Electronics
    5 Real-Time & Remote Patient Monitoring Trends 5 Real-Time & Remote Patient Monitoring Trends
    A Sentinel to Watch Over Ocular Pressure A Sentinel to Watch Over Ocular Pressure
    15. Zimmer Biomet 15. Zimmer Biomet
    20. Smith & Nephew plc 20. Smith & Nephew plc
    3D Human Heart Ventricle Model Beats and Survives Months in the Lab 3D Human Heart Ventricle Model Beats and Survives Months in the Lab
    Home Field Advantage: Examining Home Diagnostics for Chronic Disease Home Field Advantage: Examining Home Diagnostics for Chronic Disease

    Related Breaking News

    • Diagnostics
      FDA OKs First Test to Help Screen for Newborn Duchenne Muscular Dystrophy

      FDA OKs First Test to Help Screen for Newborn Duchenne Muscular Dystrophy

      PerkinElmer's test measures dried blood samples collected from the prick of a newborn’s heel 24 to 48 hours after birth.
      U.S. Food and Drug Administration 12.13.19

    • Digital Health
      New Pocket Ultrasound Scanners Smaller, More Powerful, and More Affordable

      New Pocket Ultrasound Scanners Smaller, More Powerful, and More Affordable

      Easier to use, second-generation ultra portable wireless scanners give doctors a clearer picture of what's going on.
      PR Newswire 12.12.19

    • Digital Health | Software & IT
      15-Year Tele-Critical Care Collabration Yields Significant ICU Improvement Results

      15-Year Tele-Critical Care Collabration Yields Significant ICU Improvement Results

      Florida’s first eICU, powered by Philips telehealth technology, touts reduced mortality rates and hospital stays for the sickest patients.
      GlobeNewswire 12.11.19


    • 3D/Additive Manufacturing | Software & IT
      Prellis Biologics

      Prellis Biologics' New Tool Simplifies Complex Tissue Engineering

      TissueWorkshop generates complex 3D scaffolds that can be printed with any 3D printing system.
      Krause Taylor Associates 12.11.19

    • Diagnostics
      Lens-Free Microendoscope Generates High Quality Images

      Lens-Free Microendoscope Generates High Quality Images

      It also doesn't require movement to focus on objects at different depths.
      Johns Hopkins University 12.10.19

    • Patient Monitoring | Software & IT
      Roche

      Roche's Blood Glucose Reading Smartphone App Gains CE Mark

      The app determines blood glucose ranges by taking photos with the smartphone camera without the need for a blood glucose meter.
      GlobeNewswire 12.10.19


    • Diagnostics
      NeuMoDx Molecular and Sentinel Diagnostics Partner

      NeuMoDx Molecular and Sentinel Diagnostics Partner

      Work together to develop multiple new assays for the NeuMoDx Molecular Systems.
      NeuMoDx Molecular 12.10.19

    • Diagnostics
      Companies Partner to Develop Instrument-Free Molecular Diagnostic Tests

      Companies Partner to Develop Instrument-Free Molecular Diagnostic Tests

      Collaboration facilitated by the Bill & Melinda Gates Foundation through an expansion of an existing grant.
      Business Wire 12.09.19

    • Diagnostics
      BWXT to Produce Medical Radioisotope Germanium-68 to Meet Rise in Demand

      BWXT to Produce Medical Radioisotope Germanium-68 to Meet Rise in Demand

      Company is in the process of scaling up its capacity to move into full production in 2020.
      Business Wire 12.09.19


    • Diagnostics
      FDA Clears Molecular Screening Test for Detection of Antibiotic-Resistant Bacteria

      FDA Clears Molecular Screening Test for Detection of Antibiotic-Resistant Bacteria

      BD MAX Check-Points CPO assay can identify the five most common carbapenemase genes from patients.
      BD 12.09.19

    • Diagnostics
      FDA OKs Roche

      FDA OKs Roche's Nasal Swab MRSA Test

      The cobas vivoDx MRSA test can detect the bacteria in as little as five hours.
      U.S. Food and Drug Administration 12.06.19

    • Diagnostics | Digital Health | Software & IT
      Philips & Paige to Deliver Clinical-Grade AI Applications to Pathology Labs

      Philips & Paige to Deliver Clinical-Grade AI Applications to Pathology Labs

      Aim is to help pathologists identify, quantify, and characterize cancer in tissue samples and make precise diagnoses more efficiently.
      Philips 12.05.19

    • Diagnostics | Neurological
      Eye Test for Parkinson

      Eye Test for Parkinson's Gains Breakthrough Designation

      The RightEye Vision System identifies ocular tremors that may help to detect the disease at an earlier stage.
      PR Newswire 12.05.19

    • Patient Monitoring
      FDA OKs MolecuLight

      FDA OKs MolecuLight's Handheld Fluorescence Imaging Device

      MolecuLight i:X enables real-time POC visualization of fluorescence in wounds, measures wounds, and digitally records all images and area measurements.
      PR Newswire 12.05.19

    • Diagnostics | Neurological
      RSNA News: MaxQ AI Expands Partnership with GE

      RSNA News: MaxQ AI Expands Partnership with GE

      MaxQ AI’s ACCIPIO ICH and Stroke platform will be integrated into GE Healthcare’s PACS solution.
      MaxQ Al 12.04.19


    Breaking News
    • FDA OKs World's First Single-Use Duodenoscope
    • Dr. Stephen Hahn Confirmed as New FDA Leader
    • FDA OKs First Test to Help Screen for Newborn Duchenne Muscular Dystrophy
    • MedStar Health and Cleveland Clinic Innovations Awarded Grant
    • 3M to Sell Drug Delivery Business for $650M
    View Breaking News >
    CURRENT ISSUE

    November/December 2019

    • Adding Fabrication Capabilities: Additive Manufacturing for Production Parts
    • Delivering the Goods: The Evolving World of Combination Products
    • Anxious Undertones: The 2019 Year in Review
    • View More >
    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Deerland Obtains Certification from Australia’s Therapeutic Goods Administration
    OptiMSM Shown to Improve Hair & Nail Appearance and Condition
    DCC Acquires Contract Manufacturer Ion Laboratories
    Coatings World

    Latest Breaking News From Coatings World

    Arkema: Bostik Acquires Danish Company LIP
    Axalta Adds New Epoxy Primer to Tufcote Liquid Industrial Coatings Portfolio
    Chromaflo Technologies Promotes Sergio Duenas to Country Manager of Mexico
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    FDA OKs World's First Single-Use Duodenoscope
    Dr. Stephen Hahn Confirmed as New FDA Leader
    FDA OKs First Test to Help Screen for Newborn Duchenne Muscular Dystrophy
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Sanofi Awarded $226M by US Gov't for Pandemic Influenza Preparedness
    Amgen Selects Location For R&D Facility
    Arctoris Opens Oxford R&D Facility
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Time Features 5 Best Beauty Inventions
    CES 2020 Preview - Innovation Award Honorees in Health & Wellness
    Prada & L’Oréal Sign Long-Term Licensing Deal
    Happi

    Latest Breaking News From Happi

    Cosmetic Assessments Revealed at CIR Panel
    T-Boz Launches CBD Line
    DRF and Flowerkist Develop CBD Range
    Ink World

    Latest Breaking News From Ink World

    Ripon Printers Adds Ricoh Pro C9210
    LogoJet Opens Bogota, Colombia Office
    Canon Solutions America Powers University of Notre Dame Athletics' Printing Capabilities
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    GSE products provide quality assurance for Pharmalabel
    Luminer promotes Heather Bookman to prepress manager
    Materials Exchange launches to solve excess inventory issue
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    DuPont to Acquire Osmosis Specialist
    Nice-Pak to Expand in Indiana
    Hospeco Launches Compact Fem Hy Dispenser
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    FDA OKs First Test to Help Screen for Newborn Duchenne Muscular Dystrophy
    Europe, North America Comprise More Than 80 Percent of Global Bone Marrow Transplantation Demand
    TriMed Closes Out FDA Warning Letter
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    3D Printing Materials Market to Grow at 23.9% CAGR Through 2025: GVR
    Kyocera, TactoTek Collaborate on Injection Molded Structural Electronics Solutions
    Toray Opens R&D Innovation Center for the Future

    Copyright © 2019 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.